Armata Pharmaceuticals Profit Margin

The latest profit margin for ARMP is -4383.62% as of June 2026. That compares with -755.2% in the prior-year period — down 480.5% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Armata Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, ARMP's profit margin moved from -755.2% to -4383.62% — a 480.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Armata Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, ARMP currently prints -4383.62% for profit margin, while the sector average sits near 13.89%. That is roughly 31652.6% below the sector mean. Large gaps often invite a closer look at Armata Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Armata Pharmaceuticals converts resources into returns. At -4383.62%, ARMP may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -755.2% in the prior-year period — down 480.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ARMP's profit margin (-4383.62%), review year-over-year change from -755.2%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.